• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双(-)-去甲美普他酚作为新型纳摩尔胆碱酯酶抑制剂,对β-淀粉样蛋白聚集具有高抑制活性。

Bis-(-)-nor-meptazinols as novel nanomolar cholinesterase inhibitors with high inhibitory potency on amyloid-beta aggregation.

作者信息

Xie Qiong, Wang Hao, Xia Zheng, Lu Meiyan, Zhang Weiwei, Wang Xinghai, Fu Wei, Tang Yun, Sheng Wei, Li Wei, Zhou Wei, Zhu Xu, Qiu Zhuibai, Chen Hongzhuan

机构信息

Department of Medicinal Chemistry, School of Pharmacy, Fudan University, 138 Yixueyuan Road, Shanghai, P. R. China.

出版信息

J Med Chem. 2008 Apr 10;51(7):2027-36. doi: 10.1021/jm070154q. Epub 2008 Mar 12.

DOI:10.1021/jm070154q
PMID:18333606
Abstract

Bis-(-)-nor-meptazinols (bis-(-)-nor-MEPs) 5 were designed and synthesized by connecting two (-)-nor-MEP monomers with alkylene linkers of different lengths via the secondary amino groups. Their acetylcholinesterase (AChE) inhibitory activities were more greatly influenced by the length of the alkylene chain than butyrylcholinesterase (BChE) inhibition. The most potent nonamethylene-tethered dimer 5h exhibited low-nanomolar IC 50 values for both ChEs, having a 10 000-fold and 1500-fold increase in inhibition of AChE and BChE compared with (-)-MEP. Molecular docking elucidated that 5h simultaneously bound to the catalytic and peripheral sites in AChE via hydrophobic interactions with Trp86 and Trp286. In comparison, it folded in the large aliphatic cavity of BChE because of the absence of peripheral site and the enlargement of the active site. Furthermore, 5h and 5i markedly prevented the AChE-induced Abeta aggregation with IC 50 values of 16.6 and 5.8 microM, similar to that of propidium (IC 50 = 12.8 microM), which suggests promising disease-modifying agents for the treatment of AD patients.

摘要

通过仲氨基将两个(-)-去甲美普他醇单体与不同长度的亚烷基连接基相连,设计并合成了双(-)-去甲美普他醇(bis-(-)-nor-MEPs)5。与丁酰胆碱酯酶(BChE)抑制作用相比,它们的乙酰胆碱酯酶(AChE)抑制活性受亚烷基链长度的影响更大。最有效的壬亚甲基连接的二聚体5h对两种胆碱酯酶均表现出低纳摩尔的IC50值,与(-)-美普他醇相比,对AChE和BChE的抑制作用分别增加了10000倍和1500倍。分子对接表明,5h通过与Trp86和Trp286的疏水相互作用同时结合到AChE的催化位点和外周位点。相比之下,由于缺乏外周位点和活性位点的扩大,它在BChE的大脂肪族腔中折叠。此外,5h和5i显著抑制AChE诱导的Aβ聚集,IC50值分别为16.6和5.8μM,与碘化丙啶(IC50 = 12.8μM)相似,这表明它们有望成为治疗AD患者的疾病修饰药物。

相似文献

1
Bis-(-)-nor-meptazinols as novel nanomolar cholinesterase inhibitors with high inhibitory potency on amyloid-beta aggregation.双(-)-去甲美普他酚作为新型纳摩尔胆碱酯酶抑制剂,对β-淀粉样蛋白聚集具有高抑制活性。
J Med Chem. 2008 Apr 10;51(7):2027-36. doi: 10.1021/jm070154q. Epub 2008 Mar 12.
2
Cholinesterase inhibitors: xanthostigmine derivatives blocking the acetylcholinesterase-induced beta-amyloid aggregation.胆碱酯酶抑制剂:阻断乙酰胆碱酯酶诱导的β-淀粉样蛋白聚集的黄嘌呤毒扁豆碱衍生物。
J Med Chem. 2005 Jun 30;48(13):4444-56. doi: 10.1021/jm049515h.
3
Synthesis, in vitro assay, and molecular modeling of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Abeta1-42 aggregation for Alzheimer's disease therapeutics.用于阿尔茨海默病治疗的具有双重抑制乙酰胆碱酯酶和β淀粉样蛋白1-42聚集活性的新型哌啶衍生物的合成、体外测定及分子模拟
Bioorg Med Chem. 2007 Oct 15;15(20):6596-607. doi: 10.1016/j.bmc.2007.07.003. Epub 2007 Jul 25.
4
Novel donepezil-based inhibitors of acetyl- and butyrylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation.新型基于多奈哌齐的乙酰胆碱酯酶和丁酰胆碱酯酶抑制剂以及乙酰胆碱酯酶诱导的β-淀粉样蛋白聚集。
J Med Chem. 2008 Jun 26;51(12):3588-98. doi: 10.1021/jm8001313. Epub 2008 Jun 3.
5
Design, synthesis, and biological evaluation of dual binding site acetylcholinesterase inhibitors: new disease-modifying agents for Alzheimer's disease.双结合位点乙酰胆碱酯酶抑制剂的设计、合成及生物学评价:用于阿尔茨海默病的新型疾病修饰药物
J Med Chem. 2005 Nov 17;48(23):7223-33. doi: 10.1021/jm0503289.
6
Design, synthesis, and biological evaluation of conformationally restricted rivastigmine analogues.构象受限的卡巴拉汀类似物的设计、合成及生物学评价
J Med Chem. 2004 Nov 18;47(24):5945-52. doi: 10.1021/jm049782n.
7
Novel bis-(-)-nor-meptazinol derivatives act as dual binding site AChE inhibitors with metal-complexing property.新型双(-)-去甲美普他酚衍生物作为具有金属络合性质的双结合位点 AChE 抑制剂。
Toxicol Appl Pharmacol. 2012 Oct 1;264(1):65-72. doi: 10.1016/j.taap.2012.07.018. Epub 2012 Jul 25.
8
Design, synthesis and evaluation of flavonoid derivatives as potent AChE inhibitors.黄酮类衍生物作为强效乙酰胆碱酯酶抑制剂的设计、合成与评价
Bioorg Med Chem. 2009 Sep 15;17(18):6692-8. doi: 10.1016/j.bmc.2009.07.072. Epub 2009 Aug 3.
9
Bis(9)-(-)-nor-meptazinol as a novel dual-binding AChEI potently ameliorates scopolamine-induced cognitive deficits in mice.双(9)-(-)-去甲美普他嗪作为一种新型双重结合的乙酰胆碱酯酶抑制剂,可有效改善东莨菪碱诱导的小鼠认知功能障碍。
Pharmacol Biochem Behav. 2013 Mar;104:138-43. doi: 10.1016/j.pbb.2012.11.009. Epub 2012 Dec 19.
10
New potent human acetylcholinesterase inhibitors in the tetracyclic triterpene series with inhibitory potency on amyloid β aggregation.新型四环三萜类强效人乙酰胆碱酯酶抑制剂,具有抑制淀粉样β聚集的活性。
Eur J Med Chem. 2011 Jun;46(6):2193-205. doi: 10.1016/j.ejmech.2011.02.073. Epub 2011 Mar 23.

引用本文的文献

1
Synthesis, Antiacetylcholinesterase Activity, and Molecular Dynamics Simulation of Aporphine-benzylpyridinium Conjugates.阿朴啡-苄基吡啶共轭物的合成、抗乙酰胆碱酯酶活性及分子动力学模拟
ACS Med Chem Lett. 2023 Dec 8;15(1):132-142. doi: 10.1021/acsmedchemlett.3c00467. eCollection 2024 Jan 11.
2
Claulansine F-Donepezil Hybrids as Anti-Alzheimer's Disease Agents with Cholinergic, Free-Radical Scavenging, and Neuroprotective Activities.Claulansine F-Donepezil 杂合体作为具有胆碱能、自由基清除和神经保护活性的抗阿尔茨海默病药物。
Molecules. 2021 Feb 28;26(5):1303. doi: 10.3390/molecules26051303.
3
Chromone and donepezil hybrids as new multipotent cholinesterase and monoamine oxidase inhibitors for the potential treatment of Alzheimer's disease.
色酮与多奈哌齐杂合物作为新型多效胆碱酯酶和单胺氧化酶抑制剂用于阿尔茨海默病的潜在治疗
RSC Med Chem. 2020 Jan 7;11(2):225-233. doi: 10.1039/c9md00441f. eCollection 2020 Feb 1.
4
Effects of BIS-MEP on Reversing Amyloid Plaque Deposition and Spatial Learning and Memory Impairments in a Mouse Model of β-Amyloid Peptide- and Ibotenic Acid-Induced Alzheimer's Disease.双异丙酚-甲磺酸乙酯对β-淀粉样肽和鹅膏蕈氨酸诱导的阿尔茨海默病小鼠模型中淀粉样斑块沉积及空间学习和记忆障碍的逆转作用。
Front Aging Neurosci. 2019 Jan 22;11:3. doi: 10.3389/fnagi.2019.00003. eCollection 2019.
5
Bis(9)-(-)-Meptazinol, a novel dual-binding AChE inhibitor, rescues cognitive deficits and pathological changes in APP/PS1 transgenic mice.双(9)-(-)-美普他酚,一种新型双结合乙酰胆碱酯酶抑制剂,可挽救APP/PS1转基因小鼠的认知缺陷和病理变化。
Transl Neurodegener. 2018 Sep 11;7:21. doi: 10.1186/s40035-018-0126-8. eCollection 2018.
6
Design, synthesis and evaluation of novel cinnamic acid derivatives bearing N-benzyl pyridinium moiety as multifunctional cholinesterase inhibitors for Alzheimer's disease.新型含N-苄基吡啶鎓部分的肉桂酸衍生物作为阿尔茨海默病多功能胆碱酯酶抑制剂的设计、合成与评价
J Enzyme Inhib Med Chem. 2017 Dec;32(1):776-788. doi: 10.1080/14756366.2016.1256883.
7
Pharmacophore-based design and discovery of (-)-meptazinol carbamates as dual modulators of cholinesterase and amyloidogenesis.基于药效团的(-)-美普他酚氨基甲酸酯类化合物的设计与发现:作为胆碱酯酶和淀粉样蛋白生成的双重调节剂
J Enzyme Inhib Med Chem. 2017 Dec;32(1):659-671. doi: 10.1080/14756366.2016.1265521.
8
AChE Inhibition-based Multi-target-directed Ligands, a Novel Pharmacological Approach for the Symptomatic and Disease-modifying Therapy of Alzheimer's Disease.基于乙酰胆碱酯酶抑制的多靶点导向配体,一种用于阿尔茨海默病症状性和疾病修饰治疗的新型药理学方法。
Curr Neuropharmacol. 2016;14(4):364-75. doi: 10.2174/1570159x14666160119094820.
9
Hybrids: a new paradigm to treat Alzheimer's disease.杂交体:治疗阿尔茨海默病的新范式。
Mol Divers. 2016 Feb;20(1):271-97. doi: 10.1007/s11030-015-9628-9. Epub 2015 Sep 2.
10
Virtual and In Vitro Screens Reveal a Potential Pharmacophore that Avoids the Fibrillization of Aβ1-42.虚拟筛选和体外筛选揭示了一种可避免Aβ1-42纤维化的潜在药效基团。
PLoS One. 2015 Jul 14;10(7):e0130263. doi: 10.1371/journal.pone.0130263. eCollection 2015.